Indian Agreement with USV Limited
July 07 2010 - 1:00AM
UK Regulatory
TIDMRGT
Immediate Release
7 July 2010
ReGen Therapeutics Plc
("ReGen" or the "Company")
Colostrinin(TM) distribution agreement signed for India with USV Limited
On 27 April 2010 ReGen Therapeutics Plc ('ReGen' or the 'Company') <AIM:RGT>
announced that it had appointed a leading Indian pharmaceutical company as the
exclusive distributor of ReGen's nutritional supplement Colostrinin(TM) in
India. For commercial reasons the company had requested that it remain
anonymous at that time.
ReGen can now confirm that the company is USV Limited
('USV')http://www.usvindia.com. USV Limited is a 49 year old leading healthcare
company which began as a joint venture with USV & P Inc. USA, a subsidiary of
Revlon. It's product offering today includes Active Pharmaceutical Ingredients
(APIs), Peptides, Biosimilars, Injectables, Ophthalmics and Solid Orals. USV is
planning to formally launch ColostrininTM, branded as CognateTM, in the very
near future. It's commitment to Colostrinin(TM) is shown by the fact that it
has developed and is manufacturing its own formulation specifically tailored to
the market in India.
This is the first consumer launch in a major market. India is particularly
important because it is one of the significant growth drivers of the world
economy and its large population is accustomed to self-medication. Thus, a
consumer launch in this market has significant potential for ReGen's long term
profitability.
Colostrinin(TM) is a nutritional supplement to 'support healthy brain ageing and
cognition in humans'. It is marketed as a nutritional supplement in the US,
Canada, Australia and Poland under the brand name CogniSure(TM) *, in Cyprus
under the brand name Cognase(TM) ** and in the UK under the brand name
MemoryAid***. Colostrinin(TM) is now being launched as Dyna(TM) in the Republic
of Turkey by Eczacibasi.
*CogniSure(TM) for use as a human nutraceutical is licensed in North America and
Australasia to Metagenics Inc. of San Clemente, California
(http://www.metagenics.com/).
CogniSure(TM) is distributed in Poland by Tagerr Polska, an affiliate of
Tagerr a professional services and trading company established in Köln, Germany.
(http://www.cognisure.eu/)
** Cognase(TM) is distributed in the Republic of Cyprus by Golgi Pharmaceuticals
Ltd (http://www.healthybrainaging.com/).
*** MemoryAid is distributed in the UK by PRG Nutraceuticals Ltd
(http://www.memoryaid.com/)
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel No 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel No 020 7628 3396
Nick Bealer/David Scott
Alexander David
Tel No 020 7448 9820
[HUG#1429940]
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: ReGen Therapeutics Plc via Thomson Reuters ONE
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From May 2024 to Jun 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jun 2023 to Jun 2024
